QuadMedicine, Inc.

₩3,900As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:464490Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (60.26%)
Biological Products, Except Diagnostic Substances
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap ₩44.78B
ROIC (25.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,137
6.09%
263.37%
Sell 1|12|11|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
69.51
69.43
69.28
66.68
26.24%
22.03%
18.65%
6.23%
Revenue₩B
4.927
5.200
5.478
5.528
10.06%
11.45%
14.16%
18.63%
Peers (US$33.02M)
Cap (US$)
PE
33.07M
7.715x
30.91M
—
Capital
TTM
5Y
10Y
Leveragex
0.380
0.728
0.625
EBIT/Intx
0.222
0.317
0.350
Own earn%
6.63
(170.42)
(173.79)
Sh yield%
34.71
50.75
47.77
Owners
Insiders/Inst%
3.93
55.91
Short interest%
0.91
SBC / revenue%
1.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
2–6
$1 testx
—
Incr. ROIC%
8